FABP1 and acute kidney injury: We aimed to assess the potential utility of urinary L-FABP as a biomarker for the detection of AKI in patients receiving haemopoietic stem cell transplantation utilising a semi-quantitate Point-of-Care (POC) device that could enable prompt screening of at-risk patients at the bedside.